Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases DOI Creative Commons
Xiaoxia Wang, Bai Sun,

Yujie Wang

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Янв. 30, 2024

Rheumatoid arthritis (RA) and postmenopausal osteoporosis (PMOP) are common bone-immune diseases. The imbalance between helper (Th17) regulatory T cells (Tregs) produced during differentiation of CD4 + plays a key role in bone remodelling disorders RA PMOP. However, the specific mechanism this PMOP has not been clarified. Identifying underlying Th17/Treg represents factor research development new drugs for immune In review, potential roles Th17, Treg, regulating have summarised, mechanisms by which probiotics, traditional Chinese medicine compounds, monomers maintain balance expounded. maintenance could be considered as an therapeutic alternative treatment This study also summarizes advantages disadvantages conventional treatments quality life rehabilitation patients with findings presented her will provide better understanding close relationship immunity chronic diseases ideas future research, prevention,

Язык: Английский

Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future DOI Creative Commons
Yun Zhang, Huaqiu Chen, Ran Li

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)

Опубликована: Июнь 30, 2023

Abstract Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer’s disease (AD), and its accumulation has been considered as molecular driver pathogenesis progression. Aβ prime target for development AD therapy. However, repeated failures Aβ-targeted clinical trials have cast considerable doubt on amyloid cascade hypothesis whether drug followed correct course. recent successes targeted assuaged those doubts. In this review, we discussed evolution over last 30 years summarized application diagnosis modification. particular, extensively pitfalls, promises important unanswered questions regarding current anti-Aβ therapy, well strategies further study more feasible approaches optimization prevention treatment.

Язык: Английский

Процитировано

410

Traditional Chinese medicine in COVID-19 DOI Creative Commons
Ming Lyu,

Guanwei Fan,

Guangxu Xiao

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2021, Номер 11(11), С. 3337 - 3363

Опубликована: Сен. 20, 2021

COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the globe, posing an enormous threat to public health and safety. Traditional Chinese medicine (TCM), in combination with Western (WM), made important lasting contributions battle against COVID-19. In this review, updated clinical effects potential mechanisms of TCM, presented newly recognized three distinct phases disease, are summarized discussed. By integrating available preclinical evidence, efficacies underlying TCM on COVID-19, including highly recommended patent medicines formulas, described a panorama. We hope that comprehensive review not only provides reference for care professionals recognize significant but also serves as evidence-based in-depth summary analysis facilitate understanding true scientific value TCM.

Язык: Английский

Процитировано

184

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19 DOI
Qing Hu, Yuan Xiong, Guanghao Zhu

и другие.

MedComm, Год журнала: 2022, Номер 3(3)

Опубликована: Июль 14, 2022

The main proteases (M

Язык: Английский

Процитировано

153

Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19 DOI Creative Commons
Haiyu Xu, Shufen Li, Jiayuan Liu

и другие.

Proceedings of the National Academy of Sciences, Год журнала: 2023, Номер 120(18)

Опубликована: Апрель 24, 2023

The coronavirus disease 2019 (COVID-19) pandemic is an ongoing global health concern, and effective antiviral reagents are urgently needed. Traditional Chinese medicine theory-driven natural drug research development (TCMT-NDRD) a feasible method to address this issue as the traditional formulae have been shown in treatment of COVID-19. Huashi Baidu decoction (Q-14) clinically approved formula for COVID-19 therapy with anti-inflammatory effects. Here, integrative pharmacological strategy was applied identify bioactive compounds from Q-14. Overall, total 343 chemical were initially characterized, 60 prototype Q-14 subsequently traced plasma using ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry. Among compounds, six (magnolol, glycyrrhisoflavone, licoisoflavone A, emodin, echinatin, quercetin) identified showing dose-dependent inhibition effect on SARS-CoV-2 infection, including two inhibitors (echinatin main protease (Mpro), well (glycyrrhisoflavone A) RNA-dependent RNA polymerase (RdRp). Meanwhile, three components, licochalcone B, SARS-CoV-2-infected inflammatory cell model. In addition, glycyrrhisoflavone A also displayed strong inhibitory activities against cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4). Crystal structures PDE4 complex or determined at resolutions 1.54 Å 1.65 Å, respectively, both bind active site similar interactions. These findings will greatly stimulate study TCMT-NDRD

Язык: Английский

Процитировано

85

The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives DOI Open Access
Shuo Wang,

Si-Tong Sun,

Xinyue Zhang

и другие.

International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(3), С. 2943 - 2943

Опубликована: Фев. 2, 2023

As an emerging sequencing technology, single-cell RNA (scRNA-Seq) has become a powerful tool for describing cell subpopulation classification and heterogeneity by achieving high-throughput multidimensional analysis of individual cells circumventing the shortcomings traditional detecting average transcript level populations. It been applied to life science medicine research fields such as tracking dynamic differentiation, revealing sensitive effector cells, key molecular events diseases. This review focuses on recent technological innovations in scRNA-Seq, highlighting latest results with scRNA-Seq core technology frontier areas embryology, histology, oncology, immunology. In addition, this outlines prospects its innovative application Chinese (TCM) discusses issues currently being addressed great potential exploring disease diagnostic targets uncovering drug therapeutic combination multiomics technologies.

Язык: Английский

Процитировано

77

Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine DOI Creative Commons
Ling Li, Lele Yang, Liuqing Yang

и другие.

Chinese Medicine, Год журнала: 2023, Номер 18(1)

Опубликована: Ноя. 8, 2023

Abstract Network pharmacology can ascertain the therapeutic mechanism of drugs for treating diseases at level biological targets and pathways. The effective study traditional Chinese medicine (TCM) characterized by multi-component, multi-targeted, integrative efficacy, perfectly corresponds to application network pharmacology. Currently, has been widely utilized clarify physiological activity TCM. In this review, we comprehensively summarize in TCM reveal its potential verifying phenotype underlying causes diseases, realizing personalized accurate We searched literature using “TCM pharmacology” “network as keywords from Web Science, PubMed, Google Scholar, well National Knowledge Infrastructure last decade. origins, development, are closely correlated with which applied China thousands years. have same core idea promote each other. A well-defined research strategy several aspects research, including elucidation basis syndromes, prediction targets, screening active compounds, decipherment mechanisms diseases. However, factors limit application, such selection databases algorithms, unstable quality results, lack standardization. This review aims provide references ideas encourage precise use medicine.

Язык: Английский

Процитировано

62

Speculation, climate or pandemic: Who drives the Chinese herbal medicine bubbles? DOI
Meng Qin,

Ai-Hsuan Su,

Ruifeng Li

и другие.

China Economic Review, Год журнала: 2024, Номер 87, С. 102213 - 102213

Опубликована: Июнь 7, 2024

Язык: Английский

Процитировано

27

Chrysanthemum morifolium as a traditional herb: A review of historical development, classification, phytochemistry, pharmacology and application DOI
Yuchen Liu, Chenfei Lu, Jing Zhou

и другие.

Journal of Ethnopharmacology, Год журнала: 2024, Номер 330, С. 118198 - 118198

Опубликована: Апрель 14, 2024

Язык: Английский

Процитировано

22

Recent advances in self-targeting natural product-based nanomedicines DOI Creative Commons

Haifan Liu,

Xingyue Jin, Suyi Liu

и другие.

Journal of Nanobiotechnology, Год журнала: 2025, Номер 23(1)

Опубликована: Янв. 20, 2025

Язык: Английский

Процитировано

8

Impact of sewer overflow on public health: A comprehensive scientometric analysis and systematic review DOI
Adebayo Olatunbosun Sojobi, Tarek Zayed

Environmental Research, Год журнала: 2021, Номер 203, С. 111609 - 111609

Опубликована: Июнь 30, 2021

Язык: Английский

Процитировано

101